Pharma Stocks
-
Crinetics Pharmaceuticals Surges After Vertex Agrees to Buy Company for $85 a Share
Crinetics Pharmaceuticals (CRNX) is up 98.8% today. Here is some analysis on what might have caused this price movement. Analysis:…
Read More » -
Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)
Zealand Pharma Company announcement No. 31 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)…
Read More » -
Could Buying Eli Lilly Stock Today Set You Up for Life? (Hint: Yes.)
Over the past few years, Eli Lilly (LLY +1.35%) has been offering investors a unique combination of safety and growth.…
Read More » -
Takeda Pharmaceutical (TSE:4502) Is Up 5.3% After New Insilico AI Drug Discovery Deal – Has The Bull Case Changed?
On July 2, 2026, Insilico Medicine announced a collaboration with Takeda Pharmaceutical to apply its Pharma.AI platform to discover and…
Read More » -
Index Exit and Early ALS Data Could Be A Game Changer For Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals was removed in late June 2026 from multiple Russell equity indexes, while also reporting initial Phase 1 LUMINA…
Read More » -
NewAmsterdam Pharma (NAMS) Alzheimer’s Data Push Puts Fair Value Back In Focus
Alzheimer’s data presentation puts NewAmsterdam Pharma in focus NewAmsterdam Pharma (NasdaqGM:NAMS) is drawing attention after announcing plans to present new…
Read More » -
Supernus Pharmaceuticals (SUPN) Following Shelf Filing Has Its Undervalued Case In Focus
Supernus Pharmaceuticals shelf registration puts potential equity raise in focus Supernus Pharmaceuticals (SUPN) has filed a US$177.52 million shelf registration…
Read More » -
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
Choosing between Dyne Therapeutics (DYN +5.87%) and Recursion Pharmaceuticals (RXRX +3.54%) requires balancing the potential of targeted muscle-tissue therapies against…
Read More » -
Pharma Mar, S.A. (BME:PHM) Stock Goes Ex-Dividend In Just Three Days
Pharma Mar, S.A. (BME:PHM) is about to trade ex-dividend in the next 3 days. The ex-dividend date is two business…
Read More » -
Is It Smart To Buy Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend?
It looks like Bliss GVS Pharma Limited (NSE:BLISSGVS) is about to go ex-dividend in the next three days. The ex-dividend…
Read More »